8 results on '"Yagyu, Yukinobu"'
Search Results
2. Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018.
- Author
-
Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Hayashi H, Koshi E, Kosugi T, and Yasuda Y
- Subjects
- Acute Kidney Injury blood, Acute Kidney Injury chemically induced, Age Factors, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Contrast Media administration & dosage, Contrast Media adverse effects, Creatinine blood, Diuretics adverse effects, Diuretics pharmacology, Humans, Prevalence, Prognosis, Renal Insufficiency, Chronic, Risk Factors, Saline Solution administration & dosage, United States epidemiology, Acute Kidney Injury diagnostic imaging, Acute Kidney Injury epidemiology, Contrast Media chemistry, Iodine, Radiography methods
- Published
- 2019
- Full Text
- View/download PDF
3. Contrast enhancement of intracranial lesions at 1.5 T: comparison among 2D spin echo, black-blood (BB) Cube, and BB Cube-FLAIR sequences.
- Author
-
Im S, Ashikaga R, Yagyu Y, Wakayama T, Miyoshi M, Hyodo T, Imaoka I, Kumano S, Ishii K, and Murakami T
- Subjects
- Adult, Aged, Aged, 80 and over, Artifacts, Brain anatomy & histology, Brain Neoplasms secondary, Cerebrovascular Circulation physiology, Diffusion Magnetic Resonance Imaging methods, Female, Gadolinium DTPA, Humans, Image Processing, Computer-Assisted methods, Male, Middle Aged, Phantoms, Imaging, Brain Neoplasms diagnosis, Contrast Media, Image Enhancement methods, Magnetic Resonance Imaging methods
- Abstract
Objectives: The purpose of this study was to investigate the usefulness of T1W black-blood Cube (BB Cube) and T1W BB Cube fluid-attenuated inversion recovery (BB Cube-FLAIR) sequences for contrast-enhanced brain imaging, by evaluating flow-related artefacts, detectability, and contrast ratio (CR) of intracranial lesions among these sequences and T1W-SE., Methods: Phantom studies were performed to determine the optimal parameters of BB Cube and BB Cube-FLAIR. A clinical study in 23 patients with intracranial lesions was performed to evaluate the usefulness of these two sequences for the diagnosis of intracranial lesions compared with the conventional 2D T1W-SE sequence., Results: The phantom study revealed that the optimal parameters for contrast-enhanced T1W imaging were TR/TE = 500 ms/minimum in BB Cube and TR/TE/TI = 600 ms/minimum/300 ms in BB Cube-FLAIR imaging. In the clinical study, the degree of flow-related artefacts was significantly lower in BB Cube and BB Cube-FLAIR than in T1W-SE. Regarding tumour detection, BB Cube showed the best detectability; however, there were no significant differences in CR among the sequences., Conclusions: At 1.5 T, contrast-enhanced BB Cube was a better imaging sequence for detecting brain lesions than T1W-SE or BB Cube-FLAIR., Key Points: • Cube is a single-slab 3D FSE imaging sequence. • We applied a black-blood (BB) imaging technique to T1W Cube. • At 1.5 T, contrast-enhanced T1W BB Cube was valuable for detecting brain lesions.
- Published
- 2015
- Full Text
- View/download PDF
4. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
- Author
-
Kagawa Y, Okada M, Yagyu Y, Kumano S, Kanematsu M, Kudo M, and Murakami T
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Hepatic Artery diagnostic imaging, Humans, Iodized Oil pharmacokinetics, Male, Middle Aged, Neovascularization, Pathologic, Observer Variation, Prospective Studies, Radiographic Image Enhancement methods, Carcinoma, Hepatocellular blood supply, Carcinoma, Hepatocellular diagnostic imaging, Contrast Media pharmacokinetics, Liver Neoplasms blood supply, Liver Neoplasms diagnostic imaging, Tomography, Spiral Computed methods
- Abstract
Background: A new multiphasic fast imaging technique, known as volume helical shuttle technique, is a breakthrough for liver imaging that offers new clinical opportunities in dynamic blood flow studies. This technique enables virtually real-time hemodynamics assessment by shuttling the patient cradle back and forth during serial scanning., Purpose: To determine optimal scan timing of hepatic arterial-phase imaging for detecting hypervascular hepatocellular carcinoma (HCC) with maximum tumor-to-liver contrast by volume helical shuttle technique., Material and Methods: One hundred and one hypervascular HCCs in 50 patients were prospectively studied by 64-channel multidetector-row computed tomography (MDCT) with multiphasic fast imaging technique. Contrast medium containing 600 mg iodine per kg body weight was intravenously injected for 30 s. Six seconds after the contrast arrival in the abdominal aorta detected with bolus tracking, serial 12-phase imaging of the whole liver was performed during 24-s breath-holding with multiphasic fast imaging technique during arterial phase. By placing regions of interest in the abdominal aorta, portal vein, liver parenchyma, and hypervascular HCCs on the multiphase images, time-density curves of anatomical regions and HCCs were composed. Timing of maximum tumor-to-liver contrast after the contrast arrival in the abdominal aorta was determined., Results: For the detection of hypervascular HCC at arterial phase, mean time and value of maximum tumor-to-liver contrast after the contrast arrival were 21 s and 38.0 HU, respectively., Conclusion: Optimal delay time for the hepatic arterial-phase imaging maximizing the contrast enhancement of hypervascular HCCs was 21 s after arrival of contrast medium in the abdominal aorta.
- Published
- 2013
- Full Text
- View/download PDF
5. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial.
- Author
-
Minami Y, Kudo M, Chung H, Kawasaki T, Yagyu Y, Shimono T, and Shiozaki H
- Subjects
- Aged, Aged, 80 and over, Female, Hepatectomy methods, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Treatment Outcome, Ultrasonography methods, Carcinoma, Hepatocellular diagnostic imaging, Carcinoma, Hepatocellular surgery, Contrast Media, Image Enhancement methods, Liver Neoplasms diagnostic imaging, Liver Neoplasms surgery, Surgery, Computer-Assisted methods
- Abstract
Objective: The purpose of this study was to evaluate the effectiveness of contrast harmonic sonographic guidance in radiofrequency ablation of locally progressive hepatocellular carcinoma poorly depicted with B-mode sonography., Subjects and Methods: A series of 40 patients with hepatocellular carcinoma with local tumor progression poorly depicted with B-mode sonography were randomly treated with radiofrequency ablation guided by either contrast harmonic sonography (n = 20) or conventional B-mode sonography (n = 20). Unpaired Student's t tests were performed to compare numbers of treatment sessions., Results: Treatment analysis showed that the complete ablation rate after a single treatment session was significantly higher in the contrast harmonic sonography group than in the B-mode sonography group (94.7% vs 65.0%; p = 0.043) and that the number of treatment sessions was significantly lower in the contrast harmonic sonography group (mean, 1.1 +/- 0.2 vs 1.4 +/- 0.6; p =0.037)., Conclusion: Contrast harmonic sonography-guided radiofrequency ablation is an efficient technique for guiding further ablation of local tumor progression not clearly demarcated with B-mode sonography.
- Published
- 2007
- Full Text
- View/download PDF
6. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations.
- Author
-
Yagyu Y, Awai K, Inoue M, Watai R, Sano T, Hasegawa H, and Nishimura Y
- Subjects
- Adult, Aged, Carcinoma, Hepatocellular blood supply, Female, Humans, Injections, Liver Neoplasms blood supply, Male, Middle Aged, Prospective Studies, Carcinoma, Hepatocellular diagnostic imaging, Contrast Media administration & dosage, Iopamidol administration & dosage, Liver Neoplasms diagnostic imaging, Tomography, X-Ray Computed
- Abstract
Objective: The objective of our study was to investigate the effect of different iodine concentrations in contrast materials on the depiction of hypervascular hepatocellular carcinomas (HCCs) by MDCT., Subjects and Methods: This prospective study involved 100 consecutive patients with chronic liver disease, including 27 patients with hypervascular HCCs. The first 50 patients received 100 mL of iopamidol at a concentration of 370 mg I/mL (group A) and the subsequent 50, 100 mL at 300 mg I/mL (group B); in both groups, the contrast material was administered at a rate of 3.0 mL/sec. Unenhanced scanning and four-phase enhanced scanning at 25, 40, 60, and 180 sec after the start of contrast injection were performed. The enhancement of the aorta, liver, and portal vein was measured during each phase. In addition, tumor-to-liver contrast was calculated for the 27 patients with hypervascular HCCs. Of the 27 patients with hypervascular HCCs, 15 were in group A and 12 were in group B., Results: During all phases, aortic enhancement was significantly greater in group A than group B (p < 0.01). Hepatic enhancement was significantly greater in group A than group B at 60 and 180 sec (both p < 0.01). There was no significant difference in hepatic enhancement between the two groups at 25 and 40 sec. Tumor-to-liver contrast was significantly greater in group A than group B during the late arterial phase (40 sec, p = 0.02), although there was no significant difference at 25, 60, and 180 sec., Conclusion: Contrast materials with higher iodine concentration are more effective for depicting hypervascular HCCs on MDCT during the late arterial phase.
- Published
- 2005
- Full Text
- View/download PDF
7. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
- Author
-
Awai K, Inoue M, Yagyu Y, Watanabe M, Sano T, Nin S, Koike R, Nishimura Y, and Yamashita Y
- Subjects
- Adult, Aged, Aged, 80 and over, Body Weight, Female, Humans, Injections, Intravenous, Iohexol administration & dosage, Male, Middle Aged, Portography, Prospective Studies, Statistics, Nonparametric, Time Factors, Aortography, Carcinoma, Hepatocellular diagnostic imaging, Contrast Media administration & dosage, Liver diagnostic imaging, Liver Neoplasms diagnostic imaging, Radiographic Image Enhancement methods, Tomography, Spiral Computed methods
- Abstract
Purpose: To prospectively evaluate aortic and hepatic enhancement and depiction of hypervascular hepatocellular carcinoma (HCC) between two contrast materials with moderate and high iodine concentrations when administered at same iodine dose and injection duration at multi-detector row helical computed tomography (CT)., Materials and Methods: Institutional review board approval and informed patient consent were obtained. One hundred eighty-six patients were studied, and 67 patients with hypervascular HCC were identified. Ninety-four patients were assigned to receive iohexol 350 (mg iodine per milliliter) with protocol A; 92, iohexol 300 with protocol B. In both protocols, iohexol with same iodine load per weight (518 mg/kg) was administered with same injection duration (25 seconds). Multiphase CT scanning was started 10, 20, 50, and 180 seconds after the trigger (threshold level set at increase of 100 HU over baseline CT number of aorta). Enhancement of aorta and liver was measured in 186 patients. Tumor-to-liver contrast was measured in 67 patients with hypervascular HCC. Statistical analysis was performed with Mann-Whitney U test., Results: Medians of aortic enhancement during four phases were 325, 185, 112, and 69 HU with protocol A. Corresponding values were 344, 266, 121, and 73 HU with protocol B. During all phases, aortic enhancement was significantly higher with protocol B (P = .046, P < .001, P < .001, and P = .002). Hepatic enhancement during four phases was 6, 21, 48, and 34 HU with protocol A. Corresponding values were 3, 17, 47, and 35 HU with protocol B. Hepatic enhancement was significantly higher with protocol A during first and second phases (P < .001 for both), although there was no significant difference between protocols during third and fourth phases (P = .778 and P = .178, respectively). Medians of tumor-to-liver contrast during four phases were 22, 34, 0.5, and -1.1 HU with protocol A. Corresponding values were 23, 45, 0, and -8.6 HU with protocol B. Tumor-to-liver contrast was significantly higher with protocol B during second phase (P = .049), although there was no difference between protocols during other phases., Conclusion: When total iodine dose was adjusted to body weight and injection duration was fixed, rapid administration of moderate concentration of contrast material was more effective for depiction of hypervascular HCC than was high concentration of contrast material., ((c) RSNA, 2004.)
- Published
- 2004
- Full Text
- View/download PDF
8. Optimal dose of contrast medium for depiction of hypervascular HCC on dynamic MDCT
- Author
-
Fujigai, Tetsuya, Kumano, Seishi, Okada, Masahiro, Hyodo, Tomoko, Imaoka, Izumi, Yagyu, Yukinobu, Ashikaga, Ryuichiro, Ishii, Kazunari, and Murakami, Takamichi
- Subjects
- *
CONTRAST media , *LIVER cancer , *CANCER tomography , *MEDICAL protocols , *ULTRASONIC imaging of cancer , *BODY weight - Abstract
Abstract: Purpose: The purpose of this study is to prospectively investigate the optimal dose of contrast medium for the depiction of hypervascular hepatocellular carcinoma (HCC) during the hepatic arterial phase (HAP), portal venous phase (PVP) and delayed phase (DP) of dynamic MDCT. Materials and methods: The study included 128 patients, out of these patients, 36 patients were found to have 56 hypervascular HCCs. Sixty-three patients were assigned to receive a dose of 525mgI/kg with protocol A, and 62 received a dose of 630mgI/kg with protocol B. Measurements of the attenuation values of the abdominal aorta, portal vein, hepatic vein, hepatic parenchyma and HCC during the HAP, PVP and DP were taken. Tumor-liver contrast (TLC) was calculated from the attenuation value of the hepatic parenchyma and HCC. Results: The aortic attenuation value with protocol B (351, 166, and 132HU) was significantly higher than that with protocol A (313, 153, and 120HU) during all the phases, (P <0.01 for all phases). The hepatic enhancement from unenhanced baseline with protocol B (25.2, 63.6, 50.6HU) was significantly higher than that with protocol A (20.2, 55.1 and 43.0HU) during all the phases, (P <0.01 for all phases). The TLC with protocol B (37.4, −11.8 and −13.6HU) was significantly higher than that with protocol A (28.0, −9.8 and −12.1HU) during HAP (P =0.042). Conclusion: The administration of 630mgI/kg of body weight depicts hypervascular HCC more clearly during HAP and shows sufficient hepatic enhancement of 50HU during DP. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.